February 12, 2026 · Form 4 insider transaction
TAYLOR GLEN A bought 11,250,000 shares of COCH at $0.00 per share, a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 5 days after the transaction.
The Series A-1 Warrants and Series A-2 Warrants (the "Common Warrants") will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Common Warrants (the "Stockholder Approval Date").; The Series A-1 Warrants expire on the earlier of (i) the twenty-four month anniversary of the Stockholder Approval Date and (ii) thirty days following the date the Company publicly announces that it has submitted a Premarket Approval Application (PMA) to the U.S. Food and Drug Administration for its Acclaim cochlear implant (the "Series A-1 Milestone Event").